1st Cluster | ||
Enriched Pathways | false discovery rate | strength |
miRNAs and TFs in iPS Cell Generation | 0.0021 | 2.47 |
GDNF/RET signaling axis | 0.0095 | 1.98 |
Negative regulation of miRNA transcription | 0.0189 | 1.94 |
DNA methylation | 7.62E-05 | 1.89 |
Stem cell division | 0.0293 | 1.81 |
Stem cell population maintenance | 8.70E-05 | 1.54 |
Response to retinoic acid | 0.00088 | 1.54 |
Mechanisms associated with pluripotency | 6.87E-10 | 1.51 |
Wnt signaling pathway and pluripotency | 0.0058 | 1.51 |
Signaling pathways regulating pluripotency of stem cells | 0.0031 | 1.48 |
2nd Cluster | ||
Enriched Pathways | false discovery rate | strength |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | 0.00088 | 2.74 |
Phosphorylation of Emi1 | 0.0011 | 2.66 |
PTK6 Regulates Cell Cycle | 0.0011 | 2.66 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 0.0022 | 2.44 |
Phosphorylation of the APC/C | 0.0072 | 2.14 |
Positive regulation of reactive oxygen species biosynthetic process | 0.0264 | 2.06 |
Cyclin A/B1/B2 associated events during G2/M transition | 0.0094 | 2.06 |
HDMs demethylate histones | 0.0095 | 2.04 |
Type II interferon signaling (IFNG) | 0.013 | 1.94 |
FLT3 Signaling | 0.0141 | 1.93 |
3rd Cluster | ||
Enriched Pathways | false discovery rate | strength |
MET activates PTK2 signaling | 0.013 | 2.24 |
Assembly of collagen fibrils and other multimeric structures | 1.17E-05 | 2.18 |
Collagen degradation | 1.31E-05 | 2.12 |
Matrix metalloproteinases | 0.0052 | 2.11 |
Positive regulation of collagen biosynthetic process | 0.0215 | 2.06 |
Non-integrin membrane-ECM interactions | 0.0258 | 2.06 |
Activation of Matrix Metalloproteinases | 0.0258 | 2.02 |
Collagen fibril organization | 0.0024 | 2 |
Integrin cell surface interactions | 2.90E-05 | 2 |
Collagen chain trimerization | 0.0258 | 2 |
4th Cluster | ||
Enriched Pathways | false discovery rate | strength |
FGFRL1 modulation of FGFR1 signaling | 0.000031 | 2.38 |
Phospholipase C-mediated cascade; FGFR2 | 0.000000853 | 2.36 |
FGFR2b ligand binding and activation | 0.0023 | 2.36 |
FGFR2 ligand binding and activation | 0.000000924 | 2.34 |
FGFR1 ligand binding and activation | 0.0000415 | 2.32 |
Phospholipase C-mediated cascade: FGFR1 | 0.0000473 | 2.29 |
FGFR1c ligand binding and activation | 0.0032 | 2.28 |
PI-3K cascade:FGFR2 | 0.00000166 | 2.26 |
SHC-mediated cascade:FGFR2 | 0.00000166 | 2.26 |
FRS-mediated FGFR2 signaling | 0.0000019 | 2.22 |